Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CVGW
CVGW logo

CVGW Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Calavo Growers Inc (CVGW) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
27.690
1 Day change
-1.07%
52 Week Range
28.980
Analysis Updated At
2026/05/01
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

CVGW is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a mildly bullish technical setup, but the fundamental picture is weak this quarter, there is no supportive news catalyst, and the options market is heavily bearish. Given the current data, the better call is to wait rather than buy immediately.

Technical Analysis

Current price is 27.625 versus previous close at 28.16, with the stock slightly below the recent pivot of 27.834. The trend structure is still constructive because SMA_5 > SMA_20 > SMA_200, which is bullish. MACD histogram is slightly positive at 0.0113 but contracting, meaning upside momentum is fading. RSI_6 at 61.013 is neutral-to-mildly bullish, not overbought. Key resistance sits at 28.732 and 29.287, while support is 26.937 and 26.382. Overall, the chart is positive but not strong enough to justify an urgent buy.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is clearly bearish. Put-call open interest ratio of 6.42 is very high, showing much more put positioning than call positioning. Option volume is zero today, so there is no fresh bullish flow to offset that. IV rank at 5.04 and IV percentile at 4.4 are low, suggesting the options market is not pricing in a major event-driven move right now. Net takeaway: options sentiment leans negative.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
6

Positive Catalysts

  • ["Hedge funds are buying, with buying amount up 302.03% over the last quarter.", "Gross margin improved to 12.43% in Q1 2026, up 21.98% YoY.", "Technical trend remains above the major moving averages, with SMA_5 > SMA_20 > SMA_200."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh catalyst.", "Q1 2026 revenue fell 20.85% YoY.", "Q1 2026 net income fell 83.42% YoY.", "Q1 2026 EPS fell 84.00% YoY.", "Options positioning is heavily bearish with a 6.42 put-call open interest ratio.", "Pattern-based stock trend data suggests negative near-term performance, including a 60% chance of -3.08% next day and -9.09% next month."]

Financial Performance

In Q1 2026, Calavo Growers showed weak top-line and bottom-line performance. Revenue declined to $122.2 million, down 20.85% year over year, which is a meaningful contraction. Net income fell to $732,000, down 83.42% YoY, and EPS dropped to $0.04, down 84.00% YoY. The only clear improvement was gross margin, which rose to 12.43% and was up 21.98% YoY. For a long-term investor, the earnings trend is currently too weak to support an immediate buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible recent Wall Street revision trend to summarize. Based on the available information, Wall Street pros would likely see a mixed setup: positives include hedge fund accumulation and improved gross margin, while the main cons are sharp revenue and earnings declines, lack of news catalysts, and bearish options positioning. Overall, the pro/con balance is more cautious than bullish.

Wall Street analysts forecast CVGW stock price to fall
1 Analyst Rating
Wall Street analysts forecast CVGW stock price to fall
0 Buy
1 Hold
0 Sell
Hold
Current: 27.990
sliders
Low
27
Averages
27
High
27
Current: 27.990
sliders
Low
27
Averages
27
High
27
Stephens
Stephens
Equal Weight
maintain
$28 -> $27
AI Analysis
2026-01-22
Reason
Stephens
Stephens
Price Target
$28 -> $27
AI Analysis
2026-01-22
maintain
Equal Weight
Reason
Stephens lowered the firm's price target on Calavo Growers to $27 from $28 and keeps an Equal Weight rating on the shares. Q4 results were slightly below the firm's estimates as weaker Fresh pricing and volume more than offset strong momentum in Prepared, says the analyst, who adds that the quarter was "overshadowed" by the announced agreement for Mission Produce to acquire Calavo. The firm views this as "a logical outcome" given the strategic fit and one that should help stabilize the earnings profile over time as integration synergies are pursued.
Stephens
Pooran Sharma
Equal Weight
initiated
$28
2025-09-11
Reason
Stephens
Pooran Sharma
Price Target
$28
2025-09-11
initiated
Equal Weight
Reason
Stephens analyst Pooran Sharma resumed coverage of Calavo Growers with an Equal Weight rating and $28 price target. Calavo remains highly exposed to avocado commodity pricing, which has seen near-term pressure due to elevated Peruvian supply, so the firm recommends waiting on the sidelines until pricing stabilizes and earnings visibility improves.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CVGW
Unlock Now

People Also Watch